About 5,458 results

ALLMedicine™ Angioedema Center

Research & Reviews  1,388 results

Angioedema After Favipravir Treatment: Two cases.
Journal of Cosmetic Dermatology; Islamoglu MS, Dokur M et. al.

Jan 22nd, 2022 - Drug-induced angioedema often affects elderly patients with chronic drug use. Proper diagnosis and prompt with effective treatment reduce mortality. With the increasing use of favipravir, many side effects, especially increased alanine aminotransf...

Addressing the individualized needs in hereditary angioedema: managed care strategies t...
The American Journal of Managed Care; Malesker M

Jan 19th, 2022 - Hereditary angioedema (HAE) is a serious, potentially fatal disease of recurrent swelling of various subcutaneous and submucosal tissues throughout the body. Swelling is mediated by uncontrolled regulation of bradykinin, making it pathologically d...

Bizarre Cutaneous Ulcers due to Self-Administered Intravenous Dexketoprofen Trometamol.
The International Journal of Lower Extremity Wounds; Akdogan N, Elcin G et. al.

Jan 18th, 2022 - Systemic non-steroidal anti-inflammatory drug use may result in various cutaneous complications including maculopapular rash, fixed drug eruption, urticaria, and angioedema most frequently. However extensive cutaneous ulcers in relation to intrave...

Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy.
The Journal of Allergy and Clinical Immunology; Chinthrajah RS, Jones SM et. al.

Jan 14th, 2022 - Immunotherapy is promising as an efficacious treatment for food allergy. Other food allergy treatments are also under development. However, adverse allergic events (AE) during treatment, as well as during oral food challenges (OFC) are common and ...

Management of pregnancy in hereditary angioedema in a resource constrained setting: Our...
Immunobiology Jindal AK, Barman P et. al.

Jan 12th, 2022 - Hereditary angioedema (HAE) is a rare genetic disorder distinguished clinically by recurrent episodes of non-pruritic swelling. Although pregnancy has been considered a trigger, it may have variable effect on frequency of attacks of HAE. C1-inhibi...

see more →

Guidelines  4 results

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2...
Allergy Maurer M, Magerl M et. al.

Jan 11th, 2018 - Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. I...

A consensus parameter for the evaluation and management of angioedema in the emergency ...
Academic Emergency Medicine : Official Journal of the Soc... Moellman JJ, Bernstein JA et. al.

Apr 16th, 2014 - Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioed...

A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, an...
The Journal of Allergy and Clinical Immunology; Zuraw BL, Bernstein JA et. al.

Jun 4th, 2013 - These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council ...

International consensus and practical guidelines on the gynecologic and obstetric manag...
The Journal of Allergy and Clinical Immunology; Caballero T, Farkas H et. al.

Dec 27th, 2011 - There are a limited number of publications on the management of gynecologic/obstetric events in female patients with hereditary angioedema caused by C1 inhibitor deficiency (HAE-C1-INH). We sought to elaborate guidelines for optimizing the managem...

see more →

Drugs  535 results see all →

Clinicaltrials.gov  55 results

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Jan 11th, 2022 - This is a multicenter, randomized, placebo-controlled, parallel-arm, phase 2 study to investigate the clinical efficacy, pharmacokinetics, and safety of CSL312 as prophylaxis to prevent attacks in subjects with HAE.

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS)

Jan 11th, 2022 - Factor XII is a serine protease with diverse functions that participates in coagulation, fibrinolysis, complement and contact system activation. So far, mutations in the factor XII gene were linked to the rare coagulation disorder Hagemann factor ...

Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II

Jan 6th, 2022 - This study evaluates the safety and efficacy of PHA-022121 administered orally for prophylaxis against angioedema attacks in patients with hereditary angioedema (HAE). The study will have 3 parallel arms and approximately 30 patients will be equal...

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

Jan 4th, 2022 - The main aim of this study is to compare the number of HAE attacks occuring in persons using lanadelumab with the number of HAE attacks before lanadelumab treatment was started. Data from participants who start the study after 1 March 2021, will b...

Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy

Nov 3rd, 2021 - In this prospective, randomized, single-blinded clinical trial, eligible subjects will be identified based on scheduled elective hysterectomy. Subjects with documented beta-lactam allergy in their chart will be evaluated to differentiate true alle...

see more →

News  199 results

COVID Shots Seem Safe for Hospital Staff With Allergy Risk

Nov 4th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. An analysis of self-reported allergy risk and post-COVID-19 vaccination incidents — such as hives and angioedema — among the employees of a large ...

Expert Recommendations on the Diagnosis and Management of Long COVID

Oct 5th, 2021 - It is estimated that one million people in the UK are currently living with long COVID, and with the total number of UK COVID-19 cases nearing 8 million, the further implications of long COVID for patients and healthcare services is uncertain. As ...

Quick Quiz Question 1

Oct 1st, 2021 - Correct answer: A. Rationale This patient has scromboid poisoning, which occurs when histidine is converted to histamine by bacterial enzymes in improperly refrigerated fish.

COVID-Clogged ICUs 'Terrify' Those With Chronic or Emergency Illness

Aug 31st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Jessica Gosnell, MD, 41, from Portland, Oregon, lives daily with the knowledge that her rare disease — a form of hereditary angioedema — could cau...

Berotralstat Reduces Hereditary Angioedema Attacks in Phase 3 Trial

Aug 9th, 2021 - In late 2020, the US Food and Drug Administration (FDA) approved plasma kallikrein inhibitor berotralstat, making it the first oral, once-a-day treatment available for the prevention of hereditary angioedema (HAE) attacks in patients aged 12 years...

see more →

Patient Education  2 results see all →